nvt
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
acute en chronische pijn
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
nvt
Secondary outcome
nvt
Background summary
nvt
Study objective
nvt
Study design
nvt
Intervention
nvt
Study burden and risks
nvt
Dr. Paul Janssenweg 150
5026 RH Tilburg
Nederland
Dr. Paul Janssenweg 150
5026 RH Tilburg
Nederland
Listed location countries
Age
Inclusion criteria
male
female (surgically sterilized or post-menopausal for at least two years or use for this study an acceptable method of birth control)
age 18-45 years
age 65 years and older
BMI is between 20 - 30 kg/m2 with a weight of not less than 50 kg
no smoking or you not smoking more than 10 cigarettes/day
Kidney function: for elderly CLCR > 60 mL/min; for young subjects CLCR at least 80 mL/min
Exclusion criteria
Important medical disorder, e.g., hepatitis B, cancer or HIV/AIDS.
Participation in another drug study within 60 days before the start of this study.
Blood donation within the 90 days prior to the start of this study or sudden blood loss of similar amount of blood.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
EudraCT | EUCTR2006-003982-15-NL |
CCMO | NL13752.056.06 |